Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 315.76% Upside As of ...

As a programming teaching material for children,"Arduboy" to make your own 8-bit gameWhile various things are coming out, easy-to-attach electronic tooling for children who can move toys by dragging ...

As adults, there are so many resources available to us to break into the world of programming and coding. From organizations like General Assembly and the hundreds of localized coding bootcamps, you ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical ...

Even after a 308% jump yesterday and a further 33% gain as of this afternoon, Microbot Medical Inc. (NASDAQ: MBOT) stock is trading around $13.05 but has a market capitalization of just $40 million.

Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...

Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of February 4, 2026, the average one-year price ...